Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Doximity, Inc.
High uncertainty: The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-62.3% vs price
Base Case (Median)
-44.0% vs price
Bull Case (75th pct.)
-6.2% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $11.14 | -60.1% | High (40%) |
| PE Comparable | $21.54 | -22.9% | Medium (25%) |
| Growth Trajectory DCF | $30.86 | 10.5% | Medium (20%) |
| Graham Number | $9.92 | -64.5% | Low (10%) |
| EV/EBITDA | $15.63 | -44.1% | Medium (20%) |
| EV/FCF | $33.93 | 21.5% | Medium (20%) |
| Earnings Power Value | $9.08 | -67.5% | Medium (50%) |
Based on 7 out of 7 methods, DOCS appears overvalued at the current price of $27.93. The base case fair value of $15.63 implies 44.0% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.